Click for best price
End Stage Renal Disease Drug Market Size, Share 2024
The global End Stage Renal Disease Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Calcimimetics Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of End Stage Renal Disease Drug include Pfizer Inc, AstraZeneca, Bristol-Myers Squibb Company, Dr. Reddy's Laboratories Ltd, Endo International plc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Mylan NV and Novartis AG, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
End-stage kidney disease drugs are used widely to treat end-stage kidney disease also known as the late stage renal disease, which occurs when chronic kidney disease reaches an advanced state. In this stage, the kidneys can no longer work, as they should to meet the body's needs. It damages the nephron and the kidney cannot function to remove the waste product from the body. The disease can cause other severe problems such as kidney failure, hypertension, brain aneurysm, and chronic pain.
This report aims to provide a comprehensive presentation of the global market for End Stage Renal Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding End Stage Renal Disease Drug. This report contains market size and forecasts of End Stage Renal Disease Drug in global, including the following market information:
Global End Stage Renal Disease Drug Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global End Stage Renal Disease Drug Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five End Stage Renal Disease Drug companies in 2023 (%)
We surveyed the End Stage Renal Disease Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global End Stage Renal Disease Drug Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global End Stage Renal Disease Drug Market Segment Percentages, by Type, 2023 (%)
Calcimimetics
Vitamin D
Sterols
Potassium Binders
Calcium-Based Phosphate Binders
Other
Global End Stage Renal Disease Drug Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global End Stage Renal Disease Drug Market Segment Percentages, by Application, 2023 (%)
End Stage Renal Disease Induced Hyperparathyroidism
End Stage Renal Disease Induced Hyperphosphatemia
End Stage Renal Disease Induced Hyperkalaemia
Global End Stage Renal Disease Drug Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global End Stage Renal Disease Drug Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies End Stage Renal Disease Drug revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies End Stage Renal Disease Drug revenues share in global market, 2023 (%)
Key companies End Stage Renal Disease Drug sales in global market, 2019-2024 (Estimated), (K Units)
Key companies End Stage Renal Disease Drug sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc
AstraZeneca
Bristol-Myers Squibb Company
Dr. Reddy's Laboratories Ltd
Endo International plc
Teva Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd
Mylan NV
Novartis AG
Lupin
Cipla Inc
Aurobindo Pharma
Fresenius SE & Co. KGaA
Sanofi
Takeda Pharmaceutical Company Limited
F. Hoffmann-La Roche Ltd
Kissei Pharmaceutical Co., Ltd
Abbott
Outline of Major Chapters:
Chapter 1: Introduces the definition of End Stage Renal Disease Drug, market overview.
Chapter 2: Global End Stage Renal Disease Drug market size in revenue and volume.
Chapter 3: Detailed analysis of End Stage Renal Disease Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of End Stage Renal Disease Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global End Stage Renal Disease Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
End Stage Renal Disease Drug Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
118 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 End Stage Renal Disease Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global End Stage Renal Disease Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global End Stage Renal Disease Drug Overall Market Size
2.1 Global End Stage Renal Disease Drug Market Size: 2023 VS 2030
2.2 Global End Stage Renal Disease Drug Revenue, Prospects & Forecasts: 2019-2030
2.3 Global End Stage Renal Disease Drug Sales: 2019-2030
3 Company Landscape
3.1 Top End Stage Renal Disease Drug Players in Global Market
3.2 Top Global End Stage Renal Disease Drug Companies Ranked by Revenue
3.3 Global End Stage Renal Disease Drug Revenue by Companies
3.4 Global End Stage Renal Disease Drug Sales by Companies
3.5 Global End Stage Renal Disease Drug Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 End Stage Renal Disease Drug Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers End Stage Renal Disease Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 End Stage Renal Disease Drug Players in Global Market
3.8.1 List of Global Tier 1 End Stage Renal Disease Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 End Stage Renal Disease Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global End Stage Renal Disease Drug Market Size Markets, 2023 & 2030
4.1.2 Calcimimetics
4.1.3 Vitamin D
4.1.4 Sterols
4.1.5 Potassium Binders
4.1.6 Calcium-Based Phosphate Binders
4.1.7 Other
4.2 By Type - Global End Stage Renal Disease Drug Revenue & Forecasts
4.2.1 By Type - Global End Stage Renal Disease Drug Revenue, 2019-2024
4.2.2 By Type - Global End Stage Renal Disease Drug Revenue, 2025-2030
4.2.3 By Type - Global End Stage Renal Disease Drug Revenue Market Share, 2019-2030
4.3 By Type - Global End Stage Renal Disease Drug Sales & Forecasts
4.3.1 By Type - Global End Stage Renal Disease Drug Sales, 2019-2024
4.3.2 By Type - Global End Stage Renal Disease Drug Sales, 2025-2030
4.3.3 By Type - Global End Stage Renal Disease Drug Sales Market Share, 2019-2030
4.4 By Type - Global End Stage Renal Disease Drug Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global End Stage Renal Disease Drug Market Size, 2023 & 2030
5.1.2 End Stage Renal Disease Induced Hyperparathyroidism
5.1.3 End Stage Renal Disease Induced Hyperphosphatemia
5.1.4 End Stage Renal Disease Induced Hyperkalaemia
5.2 By Application - Global End Stage Renal Disease Drug Revenue & Forecasts
5.2.1 By Application - Global End Stage Renal Disease Drug Revenue, 2019-2024
5.2.2 By Application - Global End Stage Renal Disease Drug Revenue, 2025-2030
5.2.3 By Application - Global End Stage Renal Disease Drug Revenue Market Share, 2019-2030
5.3 By Application - Global End Stage Renal Disease Drug Sales & Forecasts
5.3.1 By Application - Global End Stage Renal Disease Drug Sales, 2019-2024
5.3.2 By Application - Global End Stage Renal Disease Drug Sales, 2025-2030
5.3.3 By Application - Global End Stage Renal Disease Drug Sales Market Share, 2019-2030
5.4 By Application - Global End Stage Renal Disease Drug Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global End Stage Renal Disease Drug Market Size, 2023 & 2030
6.2 By Region - Global End Stage Renal Disease Drug Revenue & Forecasts
6.2.1 By Region - Global End Stage Renal Disease Drug Revenue, 2019-2024
6.2.2 By Region - Global End Stage Renal Disease Drug Revenue, 2025-2030
6.2.3 By Region - Global End Stage Renal Disease Drug Revenue Market Share, 2019-2030
6.3 By Region - Global End Stage Renal Disease Drug Sales & Forecasts
6.3.1 By Region - Global End Stage Renal Disease Drug Sales, 2019-2024
6.3.2 By Region - Global End Stage Renal Disease Drug Sales, 2025-2030
6.3.3 By Region - Global End Stage Renal Disease Drug Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America End Stage Renal Disease Drug Revenue, 2019-2030
6.4.2 By Country - North America End Stage Renal Disease Drug Sales, 2019-2030
6.4.3 US End Stage Renal Disease Drug Market Size, 2019-2030
6.4.4 Canada End Stage Renal Disease Drug Market Size, 2019-2030
6.4.5 Mexico End Stage Renal Disease Drug Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe End Stage Renal Disease Drug Revenue, 2019-2030
6.5.2 By Country - Europe End Stage Renal Disease Drug Sales, 2019-2030
6.5.3 Germany End Stage Renal Disease Drug Market Size, 2019-2030
6.5.4 France End Stage Renal Disease Drug Market Size, 2019-2030
6.5.5 U.K. End Stage Renal Disease Drug Market Size, 2019-2030
6.5.6 Italy End Stage Renal Disease Drug Market Size, 2019-2030
6.5.7 Russia End Stage Renal Disease Drug Market Size, 2019-2030
6.5.8 Nordic Countries End Stage Renal Disease Drug Market Size, 2019-2030
6.5.9 Benelux End Stage Renal Disease Drug Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia End Stage Renal Disease Drug Revenue, 2019-2030
6.6.2 By Region - Asia End Stage Renal Disease Drug Sales, 2019-2030
6.6.3 China End Stage Renal Disease Drug Market Size, 2019-2030
6.6.4 Japan End Stage Renal Disease Drug Market Size, 2019-2030
6.6.5 South Korea End Stage Renal Disease Drug Market Size, 2019-2030
6.6.6 Southeast Asia End Stage Renal Disease Drug Market Size, 2019-2030
6.6.7 India End Stage Renal Disease Drug Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America End Stage Renal Disease Drug Revenue, 2019-2030
6.7.2 By Country - South America End Stage Renal Disease Drug Sales, 2019-2030
6.7.3 Brazil End Stage Renal Disease Drug Market Size, 2019-2030
6.7.4 Argentina End Stage Renal Disease Drug Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa End Stage Renal Disease Drug Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa End Stage Renal Disease Drug Sales, 2019-2030
6.8.3 Turkey End Stage Renal Disease Drug Market Size, 2019-2030
6.8.4 Israel End Stage Renal Disease Drug Market Size, 2019-2030
6.8.5 Saudi Arabia End Stage Renal Disease Drug Market Size, 2019-2030
6.8.6 UAE End Stage Renal Disease Drug Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Pfizer Inc
7.1.1 Pfizer Inc Company Summary
7.1.2 Pfizer Inc Business Overview
7.1.3 Pfizer Inc End Stage Renal Disease Drug Major Product Offerings
7.1.4 Pfizer Inc End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.1.5 Pfizer Inc Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca End Stage Renal Disease Drug Major Product Offerings
7.2.4 AstraZeneca End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Bristol-Myers Squibb Company
7.3.1 Bristol-Myers Squibb Company Company Summary
7.3.2 Bristol-Myers Squibb Company Business Overview
7.3.3 Bristol-Myers Squibb Company End Stage Renal Disease Drug Major Product Offerings
7.3.4 Bristol-Myers Squibb Company End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.3.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.4 Dr. Reddy's Laboratories Ltd
7.4.1 Dr. Reddy's Laboratories Ltd Company Summary
7.4.2 Dr. Reddy's Laboratories Ltd Business Overview
7.4.3 Dr. Reddy's Laboratories Ltd End Stage Renal Disease Drug Major Product Offerings
7.4.4 Dr. Reddy's Laboratories Ltd End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.4.5 Dr. Reddy's Laboratories Ltd Key News & Latest Developments
7.5 Endo International plc
7.5.1 Endo International plc Company Summary
7.5.2 Endo International plc Business Overview
7.5.3 Endo International plc End Stage Renal Disease Drug Major Product Offerings
7.5.4 Endo International plc End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.5.5 Endo International plc Key News & Latest Developments
7.6 Teva Pharmaceutical Industries Ltd
7.6.1 Teva Pharmaceutical Industries Ltd Company Summary
7.6.2 Teva Pharmaceutical Industries Ltd Business Overview
7.6.3 Teva Pharmaceutical Industries Ltd End Stage Renal Disease Drug Major Product Offerings
7.6.4 Teva Pharmaceutical Industries Ltd End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.6.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments
7.7 Sun Pharmaceutical Industries Ltd
7.7.1 Sun Pharmaceutical Industries Ltd Company Summary
7.7.2 Sun Pharmaceutical Industries Ltd Business Overview
7.7.3 Sun Pharmaceutical Industries Ltd End Stage Renal Disease Drug Major Product Offerings
7.7.4 Sun Pharmaceutical Industries Ltd End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.7.5 Sun Pharmaceutical Industries Ltd Key News & Latest Developments
7.8 Mylan NV
7.8.1 Mylan NV Company Summary
7.8.2 Mylan NV Business Overview
7.8.3 Mylan NV End Stage Renal Disease Drug Major Product Offerings
7.8.4 Mylan NV End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.8.5 Mylan NV Key News & Latest Developments
7.9 Novartis AG
7.9.1 Novartis AG Company Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG End Stage Renal Disease Drug Major Product Offerings
7.9.4 Novartis AG End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.9.5 Novartis AG Key News & Latest Developments
7.10 Lupin
7.10.1 Lupin Company Summary
7.10.2 Lupin Business Overview
7.10.3 Lupin End Stage Renal Disease Drug Major Product Offerings
7.10.4 Lupin End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.10.5 Lupin Key News & Latest Developments
7.11 Cipla Inc
7.11.1 Cipla Inc Company Summary
7.11.2 Cipla Inc End Stage Renal Disease Drug Business Overview
7.11.3 Cipla Inc End Stage Renal Disease Drug Major Product Offerings
7.11.4 Cipla Inc End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.11.5 Cipla Inc Key News & Latest Developments
7.12 Aurobindo Pharma
7.12.1 Aurobindo Pharma Company Summary
7.12.2 Aurobindo Pharma End Stage Renal Disease Drug Business Overview
7.12.3 Aurobindo Pharma End Stage Renal Disease Drug Major Product Offerings
7.12.4 Aurobindo Pharma End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.12.5 Aurobindo Pharma Key News & Latest Developments
7.13 Fresenius SE & Co. KGaA
7.13.1 Fresenius SE & Co. KGaA Company Summary
7.13.2 Fresenius SE & Co. KGaA End Stage Renal Disease Drug Business Overview
7.13.3 Fresenius SE & Co. KGaA End Stage Renal Disease Drug Major Product Offerings
7.13.4 Fresenius SE & Co. KGaA End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.13.5 Fresenius SE & Co. KGaA Key News & Latest Developments
7.14 Sanofi
7.14.1 Sanofi Company Summary
7.14.2 Sanofi Business Overview
7.14.3 Sanofi End Stage Renal Disease Drug Major Product Offerings
7.14.4 Sanofi End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.14.5 Sanofi Key News & Latest Developments
7.15 Takeda Pharmaceutical Company Limited
7.15.1 Takeda Pharmaceutical Company Limited Company Summary
7.15.2 Takeda Pharmaceutical Company Limited Business Overview
7.15.3 Takeda Pharmaceutical Company Limited End Stage Renal Disease Drug Major Product Offerings
7.15.4 Takeda Pharmaceutical Company Limited End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.15.5 Takeda Pharmaceutical Company Limited Key News & Latest Developments
7.16 F. Hoffmann-La Roche Ltd
7.16.1 F. Hoffmann-La Roche Ltd Company Summary
7.16.2 F. Hoffmann-La Roche Ltd Business Overview
7.16.3 F. Hoffmann-La Roche Ltd End Stage Renal Disease Drug Major Product Offerings
7.16.4 F. Hoffmann-La Roche Ltd End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.16.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.17 Kissei Pharmaceutical Co., Ltd
7.17.1 Kissei Pharmaceutical Co., Ltd Company Summary
7.17.2 Kissei Pharmaceutical Co., Ltd Business Overview
7.17.3 Kissei Pharmaceutical Co., Ltd End Stage Renal Disease Drug Major Product Offerings
7.17.4 Kissei Pharmaceutical Co., Ltd End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.17.5 Kissei Pharmaceutical Co., Ltd Key News & Latest Developments
7.18 Abbott
7.18.1 Abbott Company Summary
7.18.2 Abbott Business Overview
7.18.3 Abbott End Stage Renal Disease Drug Major Product Offerings
7.18.4 Abbott End Stage Renal Disease Drug Sales and Revenue in Global (2019-2024)
7.18.5 Abbott Key News & Latest Developments
8 Global End Stage Renal Disease Drug Production Capacity, Analysis
8.1 Global End Stage Renal Disease Drug Production Capacity, 2019-2030
8.2 End Stage Renal Disease Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global End Stage Renal Disease Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 End Stage Renal Disease Drug Supply Chain Analysis
10.1 End Stage Renal Disease Drug Industry Value Chain
10.2 End Stage Renal Disease Drug Upstream Market
10.3 End Stage Renal Disease Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 End Stage Renal Disease Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of End Stage Renal Disease Drug in Global Market
Table 2. Top End Stage Renal Disease Drug Players in Global Market, Ranking by Revenue (2023)
Table 3. Global End Stage Renal Disease Drug Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global End Stage Renal Disease Drug Revenue Share by Companies, 2019-2024
Table 5. Global End Stage Renal Disease Drug Sales by Companies, (K Units), 2019-2024
Table 6. Global End Stage Renal Disease Drug Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers End Stage Renal Disease Drug Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers End Stage Renal Disease Drug Product Type
Table 9. List of Global Tier 1 End Stage Renal Disease Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 End Stage Renal Disease Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global End Stage Renal Disease Drug Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global End Stage Renal Disease Drug Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global End Stage Renal Disease Drug Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global End Stage Renal Disease Drug Sales (K Units), 2019-2024
Table 15. By Type - Global End Stage Renal Disease Drug Sales (K Units), 2025-2030
Table 16. By Application ? Global End Stage Renal Disease Drug Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global End Stage Renal Disease Drug Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global End Stage Renal Disease Drug Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global End Stage Renal Disease Drug Sales (K Units), 2019-2024
Table 20. By Application - Global End Stage Renal Disease Drug Sales (K Units), 2025-2030
Table 21. By Region ? Global End Stage Renal Disease Drug Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global End Stage Renal Disease Drug Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global End Stage Renal Disease Drug Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global End Stage Renal Disease Drug Sales (K Units), 2019-2024
Table 25. By Region - Global End Stage Renal Disease Drug Sales (K Units), 2025-2030
Table 26. By Country - North America End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America End Stage Renal Disease Drug Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America End Stage Renal Disease Drug Sales, (K Units), 2019-2024
Table 29. By Country - North America End Stage Renal Disease Drug Sales, (K Units), 2025-2030
Table 30. By Country - Europe End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe End Stage Renal Disease Drug Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe End Stage Renal Disease Drug Sales, (K Units), 2019-2024
Table 33. By Country - Europe End Stage Renal Disease Drug Sales, (K Units), 2025-2030
Table 34. By Region - Asia End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia End Stage Renal Disease Drug Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia End Stage Renal Disease Drug Sales, (K Units), 2019-2024
Table 37. By Region - Asia End Stage Renal Disease Drug Sales, (K Units), 2025-2030
Table 38. By Country - South America End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America End Stage Renal Disease Drug Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America End Stage Renal Disease Drug Sales, (K Units), 2019-2024
Table 41. By Country - South America End Stage Renal Disease Drug Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa End Stage Renal Disease Drug Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa End Stage Renal Disease Drug Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa End Stage Renal Disease Drug Sales, (K Units), 2025-2030
Table 46. Pfizer Inc Company Summary
Table 47. Pfizer Inc End Stage Renal Disease Drug Product Offerings
Table 48. Pfizer Inc End Stage Renal Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Pfizer Inc Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca End Stage Renal Disease Drug Product Offerings
Table 52. AstraZeneca End Stage Renal Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Bristol-Myers Squibb Company Company Summary
Table 55. Bristol-Myers Squibb Company End Stage Renal Disease Drug Product Offerings
Table 56. Bristol-Myers Squibb Company End Stage Renal Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Bristol-Myers Squibb Company Key News & Latest Developments
Table 58. Dr. Reddy's Laboratories Ltd Company Summary
Table 59. Dr. Reddy's Laboratories Ltd End Stage Renal Disease Drug Product Offerings
Table 60. Dr. Reddy's Laboratories Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Dr. Reddy's Laboratories Ltd Key News & Latest Developments
Table 62. Endo International plc Company Summary
Table 63. Endo International plc End Stage Renal Disease Drug Product Offerings
Table 64. Endo International plc End Stage Renal Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Endo International plc Key News & Latest Developments
Table 66. Teva Pharmaceutical Industries Ltd Company Summary
Table 67. Teva Pharmaceutical Industries Ltd End Stage Renal Disease Drug Product Offerings
Table 68. Teva Pharmaceutical Industries Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Teva Pharmaceutical Industries Ltd Key News & Latest Developments
Table 70. Sun Pharmaceutical Industries Ltd Company Summary
Table 71. Sun Pharmaceutical Industries Ltd End Stage Renal Disease Drug Product Offerings
Table 72. Sun Pharmaceutical Industries Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Sun Pharmaceutical Industries Ltd Key News & Latest Developments
Table 74. Mylan NV Company Summary
Table 75. Mylan NV End Stage Renal Disease Drug Product Offerings
Table 76. Mylan NV End Stage Renal Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Mylan NV Key News & Latest Developments
Table 78. Novartis AG Company Summary
Table 79. Novartis AG End Stage Renal Disease Drug Product Offerings
Table 80. Novartis AG End Stage Renal Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Novartis AG Key News & Latest Developments
Table 82. Lupin Company Summary
Table 83. Lupin End Stage Renal Disease Drug Product Offerings
Table 84. Lupin End Stage Renal Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Lupin Key News & Latest Developments
Table 86. Cipla Inc Company Summary
Table 87. Cipla Inc End Stage Renal Disease Drug Product Offerings
Table 88. Cipla Inc End Stage Renal Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Cipla Inc Key News & Latest Developments
Table 90. Aurobindo Pharma Company Summary
Table 91. Aurobindo Pharma End Stage Renal Disease Drug Product Offerings
Table 92. Aurobindo Pharma End Stage Renal Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Aurobindo Pharma Key News & Latest Developments
Table 94. Fresenius SE & Co. KGaA Company Summary
Table 95. Fresenius SE & Co. KGaA End Stage Renal Disease Drug Product Offerings
Table 96. Fresenius SE & Co. KGaA End Stage Renal Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Fresenius SE & Co. KGaA Key News & Latest Developments
Table 98. Sanofi Company Summary
Table 99. Sanofi End Stage Renal Disease Drug Product Offerings
Table 100. Sanofi End Stage Renal Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Sanofi Key News & Latest Developments
Table 102. Takeda Pharmaceutical Company Limited Company Summary
Table 103. Takeda Pharmaceutical Company Limited End Stage Renal Disease Drug Product Offerings
Table 104. Takeda Pharmaceutical Company Limited End Stage Renal Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. Takeda Pharmaceutical Company Limited Key News & Latest Developments
Table 106. F. Hoffmann-La Roche Ltd Company Summary
Table 107. F. Hoffmann-La Roche Ltd End Stage Renal Disease Drug Product Offerings
Table 108. F. Hoffmann-La Roche Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 109. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 110. Kissei Pharmaceutical Co., Ltd Company Summary
Table 111. Kissei Pharmaceutical Co., Ltd End Stage Renal Disease Drug Product Offerings
Table 112. Kissei Pharmaceutical Co., Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 113. Kissei Pharmaceutical Co., Ltd Key News & Latest Developments
Table 114. Abbott Company Summary
Table 115. Abbott End Stage Renal Disease Drug Product Offerings
Table 116. Abbott End Stage Renal Disease Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 117. Abbott Key News & Latest Developments
Table 118. End Stage Renal Disease Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 119. Global End Stage Renal Disease Drug Capacity Market Share of Key Manufacturers, 2021-2024
Table 120. Global End Stage Renal Disease Drug Production by Region, 2019-2024 (K Units)
Table 121. Global End Stage Renal Disease Drug Production by Region, 2025-2030 (K Units)
Table 122. End Stage Renal Disease Drug Market Opportunities & Trends in Global Market
Table 123. End Stage Renal Disease Drug Market Drivers in Global Market
Table 124. End Stage Renal Disease Drug Market Restraints in Global Market
Table 125. End Stage Renal Disease Drug Raw Materials
Table 126. End Stage Renal Disease Drug Raw Materials Suppliers in Global Market
Table 127. Typical End Stage Renal Disease Drug Downstream
Table 128. End Stage Renal Disease Drug Downstream Clients in Global Market
Table 129. End Stage Renal Disease Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. End Stage Renal Disease Drug Segment by Type in 2023
Figure 2. End Stage Renal Disease Drug Segment by Application in 2023
Figure 3. Global End Stage Renal Disease Drug Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global End Stage Renal Disease Drug Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global End Stage Renal Disease Drug Revenue, 2019-2030 (US$, Mn)
Figure 7. End Stage Renal Disease Drug Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by End Stage Renal Disease Drug Revenue in 2023
Figure 9. By Type - Global End Stage Renal Disease Drug Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global End Stage Renal Disease Drug Revenue Market Share, 2019-2030
Figure 11. By Type - Global End Stage Renal Disease Drug Sales Market Share, 2019-2030
Figure 12. By Type - Global End Stage Renal Disease Drug Price (US$/Unit), 2019-2030
Figure 13. By Application - Global End Stage Renal Disease Drug Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global End Stage Renal Disease Drug Revenue Market Share, 2019-2030
Figure 15. By Application - Global End Stage Renal Disease Drug Sales Market Share, 2019-2030
Figure 16. By Application - Global End Stage Renal Disease Drug Price (US$/Unit), 2019-2030
Figure 17. By Region - Global End Stage Renal Disease Drug Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global End Stage Renal Disease Drug Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global End Stage Renal Disease Drug Revenue Market Share, 2019-2030
Figure 20. By Region - Global End Stage Renal Disease Drug Sales Market Share, 2019-2030
Figure 21. By Country - North America End Stage Renal Disease Drug Revenue Market Share, 2019-2030
Figure 22. By Country - North America End Stage Renal Disease Drug Sales Market Share, 2019-2030
Figure 23. US End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 24. Canada End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe End Stage Renal Disease Drug Revenue Market Share, 2019-2030
Figure 27. By Country - Europe End Stage Renal Disease Drug Sales Market Share, 2019-2030
Figure 28. Germany End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 29. France End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 31. Italy End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 32. Russia End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia End Stage Renal Disease Drug Revenue Market Share, 2019-2030
Figure 36. By Region - Asia End Stage Renal Disease Drug Sales Market Share, 2019-2030
Figure 37. China End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 38. Japan End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 41. India End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America End Stage Renal Disease Drug Revenue Market Share, 2019-2030
Figure 43. By Country - South America End Stage Renal Disease Drug Sales Market Share, 2019-2030
Figure 44. Brazil End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa End Stage Renal Disease Drug Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa End Stage Renal Disease Drug Sales Market Share, 2019-2030
Figure 48. Turkey End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 49. Israel End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 51. UAE End Stage Renal Disease Drug Revenue, (US$, Mn), 2019-2030
Figure 52. Global End Stage Renal Disease Drug Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production End Stage Renal Disease Drug by Region, 2023 VS 2030
Figure 54. End Stage Renal Disease Drug Industry Value Chain
Figure 55. Marketing Channels
